BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 36059707)

  • 21. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
    DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
    Front Immunol; 2020; 11():1402. PubMed ID: 32765498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GL261 glioma tumor cells respond to ATP with an intracellular calcium rise and glutamate release.
    Strong AD; Indart MC; Hill NR; Daniels RL
    Mol Cell Biochem; 2018 Sep; 446(1-2):53-62. PubMed ID: 29318454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.
    Inoue A; Nishikawa M; Ohnishi T; Yano H; Kanemura Y; Ohtsuka Y; Ozaki S; Nakamura Y; Matsumoto S; Suehiro S; Yamashita D; Shigekawa S; Watanabe H; Kitazawa R; Tanaka J; Kunieda T
    World Neurosurg; 2021 Sep; 153():e76-e95. PubMed ID: 34144167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma.
    Duan K; Liu ZJ; Hu SQ; Huo HY; Xu ZR; Ruan JF; Sun Y; Dai LP; Yan CB; Xiong W; Cui QH; Yu HJ; Yu M; Qin Y
    Biochem Biophys Res Commun; 2018 Sep; 503(2):888-894. PubMed ID: 29928884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors.
    Marin-Valencia I; Cho SK; Rakheja D; Hatanpaa KJ; Kapur P; Mashimo T; Jindal A; Vemireddy V; Good LB; Raisanen J; Sun X; Mickey B; Choi C; Takahashi M; Togao O; Pascual JM; Deberardinis RJ; Maher EA; Malloy CR; Bachoo RM
    NMR Biomed; 2012 Oct; 25(10):1177-86. PubMed ID: 22383401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Drivers of Invasion in Glioblastoma.
    Garcia JH; Jain S; Aghi MK
    Front Cell Dev Biol; 2021; 9():683276. PubMed ID: 34277624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4.
    Wang L; Zhou H; Wang Y; Cui G; Di LJ
    Cell Death Dis; 2015 Jan; 6(1):e1620. PubMed ID: 25633289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer metabolism and intervention therapy.
    Zhao H; Li Y
    Mol Biomed; 2021 Feb; 2(1):5. PubMed ID: 35006438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy.
    Sperry J; Condro MC; Guo L; Braas D; Vanderveer-Harris N; Kim KKO; Pope WB; Divakaruni AS; Lai A; Christofk H; Castro MG; Lowenstein PR; Le Belle JE; Kornblum HI
    iScience; 2020 Sep; 23(9):101453. PubMed ID: 32861192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
    Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.
    Elsakka AMA; Bary MA; Abdelzaher E; Elnaggar M; Kalamian M; Mukherjee P; Seyfried TN
    Front Nutr; 2018; 5():20. PubMed ID: 29651419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth.
    Guido C; Whitaker-Menezes D; Lin Z; Pestell RG; Howell A; Zimmers TA; Casimiro MC; Aquila S; Ando' S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2012 Aug; 3(8):798-810. PubMed ID: 22878233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironment.
    Salem AF; Al-Zoubi MS; Whitaker-Menezes D; Martinez-Outschoorn UE; Lamb R; Hulit J; Howell A; Gandara R; Sartini M; Galbiati F; Bevilacqua G; Sotgia F; Lisanti MP
    Cell Cycle; 2013 Mar; 12(5):818-25. PubMed ID: 23388463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
    Oizel K; Chauvin C; Oliver L; Gratas C; Geraldo F; Jarry U; Scotet E; Rabe M; Alves-Guerra MC; Teusan R; Gautier F; Loussouarn D; Compan V; Martinou JC; Vallette FM; Pecqueur C
    Clin Cancer Res; 2017 Oct; 23(20):6292-6304. PubMed ID: 28720668
    [No Abstract]   [Full Text] [Related]  

  • 35. Mitochondria: The ketogenic diet--A metabolism-based therapy.
    Vidali S; Aminzadeh S; Lambert B; Rutherford T; Sperl W; Kofler B; Feichtinger RG
    Int J Biochem Cell Biol; 2015 Jun; 63():55-9. PubMed ID: 25666556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of endogenous acidic metabolic products associated with carbohydrate metabolism in tumor cells.
    Mazzio EA; Smith B; Soliman KF
    Cell Biol Toxicol; 2010 Jun; 26(3):177-88. PubMed ID: 19784859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.
    Tanaka K; Sasayama T; Irino Y; Takata K; Nagashima H; Satoh N; Kyotani K; Mizowaki T; Imahori T; Ejima Y; Masui K; Gini B; Yang H; Hosoda K; Sasaki R; Mischel PS; Kohmura E
    J Clin Invest; 2015 Apr; 125(4):1591-602. PubMed ID: 25798620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-targeting of aberrant glucose metabolism in glioblastoma.
    Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
    J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.
    Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE
    Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue.
    Whitaker-Menezes D; Martinez-Outschoorn UE; Flomenberg N; Birbe RC; Witkiewicz AK; Howell A; Pavlides S; Tsirigos A; Ertel A; Pestell RG; Broda P; Minetti C; Lisanti MP; Sotgia F
    Cell Cycle; 2011 Dec; 10(23):4047-64. PubMed ID: 22134189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.